Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer

There are a wide range of therapies for metastatic colorectal cancer (CRC) available, but outcomes remain suboptimal. Learning the role of the immune system in cancer development and progression led to advances in the treatment over the last decade. While the field is rapidly evolving, PD-1, and PD-...

Celý popis

Podrobná bibliografie

Hlavní autoři:	André F. Oliveira, Luís Bretes, Irene Furtado
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2019-05-01
Edice:	Frontiers in Oncology
Témata:	immunotherapy colorectal cancer PD-1 inhibitors PD-L1 microsatellite instability
On-line přístup:	https://www.frontiersin.org/article/10.3389/fonc.2019.00396/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!